Ivan B. LOBOV

Person

New York, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Method of treatment with a fusion protein comprising apelin and an...
- Patent number 11,642,390
- Issue date May 9, 2023
- Regeneran Pharmaceuticals, Inc.
- Panayiotis Stevis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating eye disorders with APLNR antagonists and VEGF i...
- Patent number 11,104,730
- Issue date Aug 31, 2021
- Regeneren Pharmaceuticals, Inc.
- Jingtai Cao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and formulations for treating vascular eye diseases using a...
- Patent number 11,071,780
- Issue date Jul 27, 2021
- REGENERON PHARMACEUTICALS, INC.
- Robert L. Vitti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fusion protein comprising apelin and an anti-APLNR antibody
- Patent number 10,947,310
- Issue date Mar 16, 2021
- REGENERON PHARMACEUTICALS, INC.
- Panayiotis Stevis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for treating pathological angiogenesis by administering an a...
- Patent number 10,626,173
- Issue date Apr 21, 2020
- REGENERON PHARMACEUTICALS, INC.
- Panayiotis Stevis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for improving cardiac function by administering an antibody...
- Patent number 10,189,901
- Issue date Jan 29, 2019
- REGENERON PHARMACEUTICALS, INC.
- Panayiotis Stevis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
APLNR modulators and uses thereof
- Patent number 10,155,811
- Issue date Dec 18, 2018
- REGENERON PHARMACEUTICALS, INC.
- Panayiotis Stevis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PDGFR-beta antibodies and uses thereof
- Patent number 10,023,642
- Issue date Jul 17, 2018
- REGENERON PHARMACEUTICALS, INC.
- Stanley J. Wiegand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PDGFR-beta antibodies and uses thereof
- Patent number 9,650,444
- Issue date May 16, 2017
- REGENERON PHARMACEUTICALS, INC.
- Stanley J. Wiegand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody modulators of APLNR
- Patent number 9,644,018
- Issue date May 9, 2017
- REGENERON PHARMACEUTICALS, INC.
- Panayiotis Stevis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PDGFR-beta antibodies and uses thereof
- Patent number 9,265,827
- Issue date Feb 23, 2016
- REGENERON PHARMACEUTICALS, INC.
- Stanley J. Wiegand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
In vivo angiogenesis assay
- Patent number 7,488,573
- Issue date Feb 10, 2009
- Children's Hospital Medical Center
- Richard Anthony Lang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
APLNR Modulators and Uses Thereof
- Publication number 20240091301
- Publication date Mar 21, 2024
- Regeneron Pharmaceuticals, Inc.
- Panayiotis Stevis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APLNR Modulators and Uses Thereof
- Publication number 20210403551
- Publication date Dec 30, 2021
- Regeneron Pharmaceuticals, Inc.
- Panayiotis Stevis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APLNR Modulators and Uses Thereof
- Publication number 20190177410
- Publication date Jun 13, 2019
- Regeneron Pharmaceuticals, Inc.
- Panayiotis Stevis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES
- Publication number 20190117767
- Publication date Apr 25, 2019
- Regeneron Pharmaceuticals, Inc.
- Robert L. VITTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APLNR Modulators and Uses Thereof
- Publication number 20190048074
- Publication date Feb 14, 2019
- Regeneron Pharmaceuticals, Inc.
- Panayiotis Stevis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Eye Disorders with APLNR Antagonists and VEGF I...
- Publication number 20180251545
- Publication date Sep 6, 2018
- REGENERON PHARMACEUTICAL, INC.
- Jingtai CAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APLNR Modulators and Uses Thereof
- Publication number 20170210800
- Publication date Jul 27, 2017
- Regeneron Pharmaceuticals, Inc.
- Panayiotis Stevis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PDGFR-BETA ANTIBODIES AND USES THEREOF
- Publication number 20170210813
- Publication date Jul 27, 2017
- Regeneron Pharmaceuticals, Inc.
- Stanley J. WIEGAND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES
- Publication number 20170080086
- Publication date Mar 23, 2017
- Regeneron Pharmaceuticals, Inc.
- Robert L. VITTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APLNR Modulators And Uses Thereof
- Publication number 20170058028
- Publication date Mar 2, 2017
- Regeneron Pharmaceuticals, Inc.
- Panayiotis Stevis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES
- Publication number 20160144025
- Publication date May 26, 2016
- Regeneron Pharmaceuticals, Inc.
- Robert L. VITTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PDGFR-BETA ANTIBODIES AND USES THEREOF
- Publication number 20160122433
- Publication date May 5, 2016
- Regeneron Pharmaceuticals, Inc.
- Stanley J. WIEGAND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APLNR Modulators and Uses Thereof
- Publication number 20150252107
- Publication date Sep 10, 2015
- Regeneron Pharmaceuticals, Inc.
- Panayiotis Stevis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PDGFR-beta ANTIBODIES AND USES THEREOF
- Publication number 20140193402
- Publication date Jul 10, 2014
- Regeneron Pharmaceuticals, Inc.
- Stanley J. WIEGAND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic methods for treating vascular eye disorders with DII4 a...
- Publication number 20080181893
- Publication date Jul 31, 2008
- Ivan B. Lobov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
In vivo angiogenesis assay
- Publication number 20060165595
- Publication date Jul 27, 2006
- Richard Anthony Lang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Ivan B. LOBOV

Person

Patents Grantslast 30 patents

Method of treatment with a fusion protein comprising apelin and an...

Methods of treating eye disorders with APLNR antagonists and VEGF i...

Methods and formulations for treating vascular eye diseases using a...

Fusion protein comprising apelin and an anti-APLNR antibody

Method for treating pathological angiogenesis by administering an a...

Methods for improving cardiac function by administering an antibody...

APLNR modulators and uses thereof

Anti-PDGFR-beta antibodies and uses thereof

Anti-PDGFR-beta antibodies and uses thereof

Antibody modulators of APLNR

Anti-PDGFR-beta antibodies and uses thereof

In vivo angiogenesis assay

Patents Applicationslast 30 patents

APLNR Modulators and Uses Thereof

APLNR Modulators and Uses Thereof

APLNR Modulators and Uses Thereof

METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES

APLNR Modulators and Uses Thereof

Methods of Treating Eye Disorders with APLNR Antagonists and VEGF I...

APLNR Modulators and Uses Thereof

ANTI-PDGFR-BETA ANTIBODIES AND USES THEREOF

METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES

APLNR Modulators And Uses Thereof

METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES

ANTI-PDGFR-BETA ANTIBODIES AND USES THEREOF

APLNR Modulators and Uses Thereof

ANTI-PDGFR-beta ANTIBODIES AND USES THEREOF

Therapeutic methods for treating vascular eye disorders with DII4 a...

In vivo angiogenesis assay